Y-mAbs Therapeutics
YMAB
#6603
Rank
A$0.80 B
Marketcap
$17.91
Share price
-12.06%
Change (1 day)
134.23%
Change (1 year)

Y-mAbs Therapeutics (YMAB) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : A$75.26 Million

According to Y-mAbs Therapeutics 's latest financial reports the company's total liabilities are A$75.26 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Y-mAbs Therapeutics - Total liabilities on balance sheet (from 2017 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$39.45 M-16.7%
2022-12-31A$47.36 M5.09%
2021-12-31A$45.07 M32.23%
2020-12-31A$34.08 M36.67%
2019-12-31A$24.94 M54.17%
2018-12-31A$16.17 M26.62%
2017-12-31A$12.77 M77.11%
2016-12-31A$7.21 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$40.96 M-45.57%๐Ÿ‡บ๐Ÿ‡ธ USA